Evidence map›Paper›PMID 35759043›Full record

ReviewOrthopadie (Heidelberg, Germany)2022

[Partial or full component exchange in hip revision? : The relevance of off-label use and mix & match].

K P Günther, K Tucker, P Kjaersgaard-Andersen, J Lützner, J P Kretzer, R Nelissen, T Lange, L Zagra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Orthopadie (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K P GüntherUniversitätsCentrum für Orthopädie, Unfall- und Plastische Chirurgie, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. klaus-peter.guenther@uniklinikum-dresden.de.
K TuckerOrthopaedic Data Evaluation Panel (ODEP), Norwich, Großbritannien.
P Kjaersgaard-AndersenDepartment of Orthopaedics, Vejle Hospital, South Danish University, Vejle, Dänemark.
J LütznerUniversitätsCentrum für Orthopädie, Unfall- und Plastische Chirurgie, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.
J P KretzerLaboratory of Biomechanics and Implant Research, Clinic for Orthopedics and Trauma Surgery, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
R NelissenDepartment of Orthopaedics, Leiden University Medical Center, Leiden, Niederlande.
T LangeCenter for Evidence-based Healthcare, University Hospital Carl Gustav Carus and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Deutschland.
L ZagraHip Department, IRCCS Istituto Ortopedico Galeazzi, Mailand, Italien.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Off-label use is frequently practiced in hip revision arthroplasty, as there may be indications for the application of implants for purposes outside the one the manufacturers intended (i.e. large bone and soft tissue defects, obesity). Patients may also benefit from selective application of mix & match in hip revision, when the exchange of one component only is necessary and the invasiveness of surgery can be reduced. Currently, there are no formal guidelines for these situations. Therefore, within a recent EFORT initiative, evidence- and consensus-based recommendations have been developed for the safe application of off-label use and mix & match in revision hip and knee arthroplasty.

Indexed as

Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeHip ProsthesisHumansOff-Label UseConsensus developmentGuidelineHip revision surgeryObesityTotal hip arthroplasty

Identifiers

PMID35759043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.